Physician profile
Bridget S Brunner
NPI 1427272129
$4,687.06
in general payments reported to CMS, 2019-2025
32 companies · $629 in 2025
The $629 reported for 2025 was more than what 85% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $440 · 2020: $171 · 2021: $430 · 2022: $415 · 2023: $269 · 2024: $2,334 · 2025: $629.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Long Term Medical Supply Or Device Loan: $1,980 · Food and Beverage: $1,251.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Long Term Medical Supply Or Device Loan | $1,979.81 |
| Food and Beverage | $1,251.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Integra Lifesciences Corporation | $1,979.81 | 2024 | Integra |
| Abbvie INC. | $346.84 | 2019-2023 | Liletta |
| Astellas Pharma US INC | $293.44 | 2019-2025 | Veozah, Myrbetriq |
| Sumitomo Pharma America, INC. | $286.24 | 2023-2025 | Gemtesa, Myfembree |
| Takeda Pharmaceuticals U.S.A., INC. | $197.14 | 2019-2023 | Trintellix |
| Ardelyx, INC. | $159.54 | 2024-2025 | Ibsrela |
| Boston Scientific Corporation | $156.10 | 2019-2022 | |
| Shield Therapeutics INC | $138.33 | 2023-2025 | Accrufer |
| Duchesnay USA Incorporated | $126.76 | 2019 | |
| Ethicon US, LLC | $101.47 | 2023-2025 | Enseal X1, Ethicon, Surgicel Nu-Knit |
| Novo Nordisk INC | $100.36 | 2022-2024 | Wegovy |
| Mayne Pharma Commercial LLC | $90.04 | 2023-2025 | |
| Therapeuticsmd, INC. | $64.23 | 2019-2022 | |
| Exeltis, USA INC. | $59.87 | 2021-2025 | Slynd |
| Aspira Women'S Health INC | $52.62 | 2021 |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $45.86 | 2019-2025 | Prolia, Evenity |
| Urovant Sciences INC | $43.28 | 2021-2022 | |
| Radius Health, INC. | $42.18 | 2019 | |
| Hologic Sales and Service, LLC | $37.43 | 2021-2023 | Acessa Provu System |
| Amag Pharmaceuticals, INC. | $36.60 | 2019-2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $36.34 | 2019-2020 | |
| Intuitive Surgical, INC. | $35.39 | 2022 | |
| Evofem Biosciences, INC. | $35.26 | 2021 | |
| Sage Therapeutics, LLC | $33.73 | 2024-2025 | Zurzuvae |
| Pfizer INC. | $33.59 | 2019 | |
| Lilly USA, LLC | $30.66 | 2024 | Zepbound, Jardiance |
| Bayer Healthcare Pharmaceuticals INC. | $26.00 | 2025 | |
| Covidien LP | $23.03 | 2019 | |
| Baxter Healthcare | $21.19 | 2022 | |
| Axonics, INC. | $19.66 | 2023 | Axonics |
| Scynexis, INC. | $18.92 | 2022 | |
| Myovant Sciences INC. | $15.15 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bridget Brunner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.